Antihypertensive Properties of a Pea Protein Hydrolysate during Short- and Long-Term Oral Administration to Spontaneously Hypertensive Rats

Journal of Food Science

Volumn 81, Issue 5, 2016, Pages H1281-H1287

  Girgih, Abraham T ^a   Nwachukwu, Ifeanyi D ^a   Onuh, John O ^a   Malomo, Sunday A ^a   Aluko, Rotimi E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Angiotensin converting enzyme; Pea protein hydrolysate; Pea protein isolate; Renin; Spontaneously hypertensive rats

Indexed keywords

AMINO ACID; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PEPTIDE; PLANT PROTEIN; PROTEIN HYDROLYSATE; PROTEIN INTAKE; RENIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD PRESSURE; CHEMISTRY; DRUG EFFECTS; HEAT; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PEA; PHARMACOLOGY; PROTEIN INTAKE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; THERAPEUTIC USE;

ADMINISTRATION, ORAL; AMINO ACIDS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIETARY PROTEINS; HOT TEMPERATURE; HYPERTENSION; MALE; PEAS; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; PLANT PROTEINS; PROTEIN HYDROLYSATES; RATS, INBRED SHR; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84962691499     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.13272     Document Type: Article

References (42)

1. Abassi Z, Winaver J, Feuerstein GZ. 2009. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality. Biochem Pharmacol 78:933-40.
2. Alashi AM, Blanchard CL, Mailer RJ, Agboola SO, Mawson AJ, He R, Malomo SA, Girgih AT, Aluko RE. 2014. Blood pressure lowering effects of Australian canola protein hydrolysates in spontaneously hypertensive rats. Food Res Int 55:281-7.
3. Aluko RE. 2015. Antihypertensive peptides from food proteins. Annu Rev Food Sci Technol 6:235-62.
4. Azizi M. 2008. Direct renin inhibition: clinical pharmacology. J Mol Med 86:647-54.
5. Bidlingmeyer BA, Cohen SA, Tarvin TL. 1984. Rapid analysis of amino-acids using pre-column derivatization. J Chromatogr 336:93-104.
6. Blumentals WA, Brown RR, Gomez-Caminero A. 2003. Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients. Intl J Impotence Res 15:314-7.
7. Fitzgerald C, Mora-Soler L, Gallagher E, O'Connor P, Prieto J, Soler-Vila A, Hayes M. 2012. Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga Palmaria palmata. J Agric Food Chem 60:7421-7.
8. Fitzgerald C, Aluko RE, Hossain M, Rai DK, Hayes M. 2014. Potential of a renin inhibitory peptide from the red seaweed palmaria palmata as a functional food ingredient following confirmation and characterization of a hypotensive effect in spontaneously hypertensive rats. J Agric Food Chem 62:8352-6.
9. Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L. 2001. Sexual activity in hypertensive men treated with valsartan or carvediol: a crossover study. Am J Hypertens 14:27-31.
10. Fouad-Tarazi F, Bumpus M, Khosla M, Healy B. 1988. The renin-angiotensin system and treatment of heart failure. Am J Med 84 (Suppl. 3A):83-6.
11. Gehrke CW, Wall LL, Absheer JS, Kaiser FE, Zumwalt RW. 1985. Sample preparation for chromatography of amino-acids: acid-hydrolysis of proteins. J Assoc Official Anal Chem 68:811-21.
12. Girgih AT, Udenigwe CC, Li H, Adebiyi AP, Aluko RE. 2011. Kinetics of enzyme inhibition and antihypertensive effects of hemp seed (Cannabis sativa L.) protein hydrolysates. J Am Oil Chem Soc 88:1767-74.
13. Girgih AT, Alashi A, He R, Malomo S, Aluko RE. 2014a. Preventive and treatment effects of a hemp seed (Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats. Eur J Nutr 53:1237-46.
14. Girgih AT, He R, Malomo S, Offengenden M, Wu J, Aluko RE. 2014b. Structural and functional characterization of hemp seed (Cannabis sativa L.) protein-derived antioxidant and antihypertensive peptides. J Funct Foods 6:384-94.
15. Gunkel AR, Thurner KH, Kanonier G, Sprinzl GM, Thumfart WF. 1996. Angioneurotic edema as a reaction to angiotensin-converting enzyme inhibitors. Am J Otolaryngol 17:87-91.
16. Harel Z, Gilbert C, Wald R, Bell C, Perl J, Juurlink D, Beyene J, Shah PS. 2012. The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis. Br Med J 344:e42.
17. He R, Alashi A, Malomo SA, Girgih AT, Chao D, Ju X, Aluko RE. 2013a. Antihypertensive and free radical scavenging properties of enzymatic rapeseed protein hydrolysates. Food Chem 141:153-9.
18. He R, Malomo SA, Alashi A, Girgih AT, Ju X, Aluko RE. 2013b. Purification and hypotensive activity of rapeseed protein-derived renin and angiotensin converting enzyme inhibitory peptides. J Funct Foods 5:781-9.
19. Huang W-H, Sun J, He H, Dong H-W, Li J-T. 2011. Antihypertensive effect of corn peptides, produced by a continuous production in enzymatic membrane reactor, in spontaneously hypertensive rats. Food Chem 128:968-73.
20. Jimsheena VK, Gowda LR. 2011. Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion. Food Chem 125:561-9.
21. Kodero T, Nio N. 2006. Identification of an angiotensin I-converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in spontaneously hypertensive rats. J Food Sci 71:C164-73.
22. Koyama M, Hattori S, Amano Y, Watanabe M, Nakamura K. 2014. Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: a new approach to estimating ACE-inhibitory activity. PLoS ONE 9:e105802.
23. Landry J, Delhaye S. 1992. Simplified procedure for the determination of tryptophan of foods and feedstuffs from barytic hydrolysis. J Agric Food Chem 40:776-9.
24. Law M, Wald N, Morris J. 2003. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess 7:1-94.
25. Li H, Aluko RE. 2010. Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate. J Agric Food Chem 58:11471-6.
26. Li H, Prairie N, Udenigwe CC, Adebiyi AP, Tappia PS, Aukema HM, Jones PJH, Aluko RE. 2011. Blood pressure lowering effect of a pea protein hydrolysate in hypertensive rats and humans. J Agric Food Chem 59:9854-60.
27. Marczak ED, Usui H, Fujita H, Yang Y, Yokoo M, Lipkowski AW, Yoshikawa M. 2003. New antihypertensive peptides isolated from rapeseed. Peptides 24:791-8.
28. Markwell MAK, Haas SM, Bieber LL, Tolbert NE. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206-10.
29. Nabha L, Garbern JC, Buller CL, Charpie JR. 2005. Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens 27:71-82.
30. Nickel GB. 1981. Process for preparing products from legumes. Canadian Patent 1104871.
31. O'Brien E, Barton J, Nussberger J, Mulcahy D, Jensen C, Dicker P, Stanton A. 2007. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. Hypertens 49:276-84.
32. Peach MJ. 1997. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57:313-70.
33. Rho SJ, Lee JS, Chung YI, Kim YW, Lee HG. 2009. Purification and identification of an angiotensin I-converting enzyme inhibitory peptide from fermented soybean extract. Process Biochem 44:490-3.
34. Satake M, Enjoh M, Nakamura Y, Takano T, Kawamura Y, Arai S, Shimizu M. 2002. Transepithelial transport of the bioactive peptides, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 66:378-84.
35. Seguro-Campos MR, González FP, Geurrero LC, Ancona DB. 2013. Angiotensin I-converting enzyme inhibitory peptides of chia (Salvia hispanica) produced by enzymatic hydrolysis. Intl J Food Sci 2013, Article ID 158482, 8 pages.
36. Tenenbaum A, Grossman E, Shemesh J, Fisman EZ, Nosrati I, Motro M. 2000. Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens 13:776-82.
37. Udenigwe CC, Aluko RE. 2012. Food protein-derived bioactive peptides: production, processing, and potential health benefits. J Food Sci 77:R11-R24.
38. Udenigwe CC, Lin Y-S, Hou W-C, Aluko RE. 2009. Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. J Funct Foods 1:199-207.
39. Udenigwe CC, Adebiyi AP, Doyen A, Li H, Bazinet L, Aluko RE. 2012. Low molecular weight flaxseed protein-derived arginine-containing peptides reduced blood pressure of spontaneously hypertensive rats faster than amino acid form of arginine and native flaxseed protein. Food Chem 132:468-75.
40. WHO, World Health Organization. World Health Day. A global briefing on hypertension. http://apps.who.int/iris/bitstream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.pdf
41. Yang HYT, Erdös EG, Levin Y. 1970. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 214:374-6.
42. Yuan L, Wu J, Aluko RE. 2007. Size of the aliphatic chain of sodium houttuyfonate analogs determines their affinity for renin and angiotensin I converting enzyme. Intl J Biol Macromol 41:274-80.